Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06857877 · ClinicalTrials.gov registry record
Arlington Aging Study
A clinical trial of Aging, sponsored by The University of Texas at Arlington.
- Recruiting
- Registry status
- 770
- Enrollment target
- 1
- Study location
NCT06857877: Recruiting study of Aging, sponsored by The University of Texas at Arlington.
NCT06857877 is a study of Aging that is actively recruiting participants, run by The University of Texas at Arlington. The registered enrollment target is 770 participants, below the 2,192-participant average among 262 other Aging trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06857877, a study of Aging, is actively recruiting participants, sponsored by The University of Texas at Arlington.
- RECRUITING
- Registry status
- 770 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn about the mechanisms causing functional decline with age, using exercise science, neuroscience, and remote monitoring. Specific aims include: Aim 1: Advance knowledge of the biology of aging and its impact on the prevention, progression, and prognosis of disease and disability. Aim 2: Determine the effects of personal and societal factors on aging. Aim 3: Examine the influence of racial/ethnic and sex differences on the biology of aging and its impact on the prevention, progression, and prognosis of disease and disability.
Primary Outcome
Olfactory Testing will be assessed using the NIH Toolbox Odor Identification cards. After scratching a card and sniffing from each sample, respondents will be asked to choose the best match for each odor from pictures representing the odor sources.
Conditions Studied
Study Locations (1)
Texas
- University of Texas Arlington - Arlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 770 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2030-12-31 |
What NCT06857877 shows while recruiting
NCT06857877 is an observational study that tracks outcomes without assigning an intervention. The registered 770 participants enrollment target is mid-sized for trials with a published cap, below the 2,192-participant average among 262 other Aging trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 0 interventions.
NCT06857877 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06857877 about?
NCT06857877 is a clinical study titled "Arlington Aging Study". The goal of this observational study is to learn about the mechanisms causing functional decline with age, using exercise science, neuroscience, and remote monitoring. Specific aims include: Aim 1: Advance knowledge of the biology of aging and its impact on the prevention, progression, and prognos...
What is the current status of trial NCT06857877?
This trial is currently recruiting. The enrollment target is 770 participants. The study started on 2024-09-01. Estimated completion is 2030-12-31.
What conditions does trial NCT06857877 study?
This clinical trial studies the following conditions: Aging.
Who is sponsoring clinical trial NCT06857877?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06857877 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06857877's enrollment target sits among peer trials
770 17th of 262 higher than 246 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
RECRUITING · Phase 4
-
Effect of a Daily Supplement on Plasma PAI-1 Levels
RECRUITING · Phase 1
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05977348 · 770 participants · NA
Increasing Food Literacy in Preschoolers to Reduce Obesity Risk
- NCT06376994 · 770 participants · Phase 3
Multi-Center Clean Air Randomized Controlled Trial in COPD
- NCT06824467 · 770 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- NCT06907173 · 770 participants · Phase 3
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI